SEC Form 4 · accession 0001609351-17-000047
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alert Lorris Betz
Director
Period of report
May 31, 2017
Accepted (ET)
Jun 2, 2017 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $50.93 | May 31, 2017 | A | 4,000 | A | May 31, 2018 | May 30, 2027 | Common Stock | 4,000 | 4,000 | D |
| Restricted Stock UnitsF1,F2,F3 | — | May 31, 2017 | A | 1,500 | A | — | — | Common Stock | 1,500 | 1,500 | D |
Explanation of responses
- F1The reporting person is the member of the board of trustees of The Children Hospital of Philadelphia Foundation ("CHOP Foundation"), and he holds these securities for the benefit of CHOP Foundation.
- F2Each restricted stock unit represents a contingent right to receive one share of Spark Therapeutics, Inc. common stock.
- F3100% of the restricted stock awards vest on the one-year anniversary of the grant date. Vested shares will be delivered to the reporting person on the vesting date.